Abstract
Ultrasound technology has traditionally been pivotal in diagnostic imaging and therapeutic treatments. However, the advent of “sonobiopsy” has expand its application into molecular diagnosis. Sonobiopsy leverages ultrasound to noninvasively release disease-specific biomarkers into the bloodstream. This innovative approach enables spatially targeted and temporally controlled detection of disease-specific circulating biomarkers, offering a significant advancement in disease diagnosis. Initially conceptualized in 2009 by Gary Glazer's team at Stanford University, sonobiopsy has rapidly emerged as a groundbreaking technique. It is particularly promising in diagnosing brain diseases and other conditions, offering a less invasive alternative to traditional methods. This presentation aims to provide a comprehensive overview of the sonobiopsy field. It will cover its development, current applications, and potential future implications in medical diagnostics. The discussion will include insight into how sonobiopsy offers a more precise, controlled, and patient-friendly approach to disease detection, underscoring its growing importance in medicine.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
